Fundraising Fox

TransEnterix

Morrisville, US · Delaware corporation · 273 employees on LinkedIn · 4 known investors

Asensus Surgical (formerly TransEnterix) develops robotic-assisted surgical systems and augmented intelligence technology, including reusable instruments, to give surgeons real-time information during procedures. Its products serve surgeons and hospitals in the operating room across international markets.

Founders & leadership

AF
Anthony FernandoExecutive
TM
Todd M PopeExecutive
JP
Joseph P SlatteryExecutive
JO
John OnopchenkoNamed on SEC filing
TM
Todd M. PopeNamed on SEC filing
WN
William N. StarlingNamed on SEC filing
DM
David MilneNamed on SEC filing
MR
Matt RiekeNamed on SEC filing
RP
Richard Pfenniger, Jr.Named on SEC filing
JJ
James J. MartinNamed on SEC filing
JH
Jane H. HsiaoNamed on SEC filing
KT
Kevin T. WayneNamed on SEC filing

Investors · 4

Reported raises · per SEC filings

Form D private placements

$24.6M disclosed across 4 rounds · 2011–2017

$950KraisedSep 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul A LaVioletteDirector
  • Aftab R KheraniDirector
  • Richard, Jr. C PfennigerDirector
  • Andrea BiffiDirector
  • Todd M PopeExecutive Officer, Director
  • David B MilneDirector
  • Jane H HsiaoDirector
  • Joseph P SlatteryExecutive Officer
  • William N KelleyDirector
  • Anthony FernandoExecutive Officer
  • William, Jr. N StarlingDirector
Offering amount
$950K
Amount sold
$950K
First sale
Sep 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$115.7KraisedSep 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony FernandoExecutive Officer
  • Paul A LaVioletteDirector
  • Jane H HsiaoDirector
  • William N KelleyDirector
  • Andrea BiffiDirector
  • William, Jr. N StarlingDirector
  • Aftab R KheraniDirector
  • David B MilneDirector
  • Richard, Jr. C PfennigerDirector
  • Todd M PopeExecutive Officer, Director
  • Joseph P SlatteryExecutive Officer
Offering amount
$214.2K
Amount sold
$115.7K
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8.3MraisedFeb 2012 · 36 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard Pfenniger, Jr.Director
  • James J. MartinExecutive Officer
  • Jane H. HsiaoDirector
  • Kevin T. WayneDirector
  • Charles J. FilipiExecutive Officer, Director
  • Chao C. ChenDirector
  • Jeffrey G. SpragensExecutive Officer, Director
  • Steven D. RubinDirector
Offering amount
$8.3M
Amount sold
$8.3M
First sale
Feb 2012
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗
$15.2MraisedFeb 2012 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew SchiffDirector
  • Paul La VioletteDirector
  • John OnopchenkoDirector
  • Todd M. PopeExecutive Officer, Director
  • William N. StarlingDirector
  • Dennis DoughertyDirector
  • David MilneDirector
  • Matt RiekeDirector
Offering amount
$16M
Amount sold
$15.2M
First sale
Nov 2011
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

What does TransEnterix do?
Asensus Surgical (formerly TransEnterix) develops robotic-assisted surgical systems and augmented intelligence technology, including reusable instruments, to give surgeons real-time information during procedures. Its products serve surgeons and hospitals in the operating room across international markets.
Who are TransEnterix's investors?
TransEnterix's investors include Aisling Capital, SV Health Investors, Quaker BioVentures, SV Life Sciences.
How much funding has TransEnterix raised?
TransEnterix has disclosed $24.6M raised across 4 rounds.
Where is TransEnterix headquartered?
TransEnterix is headquartered in Morrisville, US.